The pattern of HIV-associated dyslipidemia does not mirror that seen in the general population, and within HIV it differs between those who are on ART and those who are not. The change in ...
The principal dyslipidemia induced by HIV infection ... produce a specific dyslipidemia that may contribute to accelerated atherosclerosis and increased CVD risk, particularly in an aging cohort.
Given the fundamental contribution of circulating LDL-C to atherosclerosis, we hypothesize that liver epsins promote atherosclerosis by controlling PCSK9-triggered LDLR endocytosis and degradation.
Inflammation and immunosuppressive therapies contribute to forms of dyslipidemia with features that are unique to specific diseases ... The formation of oxLDL is a key driver of atherosclerosis, and ...
Dyslipidemia and increased risk of atherosclerosis were found in TDT children, as they had elevated atherogenic lipid indexes. Our study underlines the importance of the routine use of these indexes ...
Cardiovascular diseases remain a leading cause of mortality globally, particularly among individuals with both obstructive sleep apnea (OSA) and metabolic syndrome (MetS).
Hyperuricemia (HU), characterized by elevated uric acid (UA) levels in the blood, is a global health concern associated with various conditions, including cardiovascular diseases, gout, hypertension, ...